FDA expands indications for BLUJEPA FDA Approval Dec. 31, 2025, 13:45 UTC GLAXOSMITHKLINE receives approval for new indications. Submission: SUPPL-1. Decision date: 12/11/2025 Full text
There are no comments here yet...